Search results
2-in-1 shot for flu and COVID shows promise in advanced trial
Live Science via Yahoo News· 6 days agoModerna representatives told news outlets that the company aspires to have the new shot approved by...
Takeda circles a leukemia drug; J.P. Morgan moves into biotech investing
BioPharma Dive via Yahoo Finance· 2 days agoThe Japanese pharma paid $100 million to secure option rights to an Ascentage drug. Elsewhere, J.P....
What is COVID KP.3 variant? Symptoms, CDC data, what to know about the newest COVID strain
USA TODAY via Yahoo News· 5 days agoContributing: Eduardo Cuevas... Team at USA TODAY. Ahjané covers breaking news, car recalls, crime, health, lottery and public policy stories. Email her at aforbes...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
AOL· 1 day agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update their formulas for fall doses, in an attempt to target the KP.2 strain of the JN.1 variant ...
Analysis | Court rejects abortion pill challenge, but what happens next?
Washington Post· 2 days agoWhat do you think is next in the fight over medication abortion? Today’s edition: Senate Republicans...
National Academies Issue New Broad Definition of Long COVID
Medscape· 5 days agoA new broadly inclusive definition of long COVID from the National Academies of Sciences,...
Moderna director Afeyan sells over $30 million in company stock By Investing.com
Investing.com· 5 days agoModerna , Inc. (NASDAQ:MRNA) Director Noubar Afeyan has sold a significant number of company shares,...
2-in-1 shot for flu and COVID shows promise in advanced trial
LiveScience· 6 days agoAn experimental two-in-one vaccine triggered strong immune responses against both the flu and SARS-CoV-2, the virus behind COVID-19, in an advanced clinical trial that included adults ages 50 ...